<i>In Vitro</i> and <i>In Vivo</i> biocompatibility study on acellular sheep periosteum for guided bone regeneration.
This study addresses the fabrication of an extracellular matrix material of acellular sheep periosteum, and systematic evaluation of its biocompatibility to explore its potential application in guided bone regeneration. Sheep periosteum was harvested and decellularized by a combined decellularization protocol. The effectiveness of cell removal was proved and residual α-Gal antigen was also quantitively detected. Then, mouse MC3T3-E1 cells were seeded onto the acellular periosteum. Scanning electron microscope (SEM) was used to record the whole process of cell adhesion. CCK-8 assay suggested that the acellular periosteum not only had zero toxic effect on pre-osteoblasts, but played a positive role in cell proliferation. It was also tested that whether the acellular periosteum possess favorable osteogenesis induction activity attributed to ALP assay and quantitative real-time PCR (Col I, Runx2, OCN) assay. In vivo study of subcutaneous implantation test using SD rats was performed to detect the changes of IL-2, IFN-γ, IL-4 in serum and elucidate the host's local response to acellular periosteum through HE and immunohistochemical staining. The results show that acellular sheep periosteum did not elicit a severe immunogenic response via Th1 pathway unlike fresh sheep periosteum. In conclusion, acellular sheep periosteum possesses favorable biocompatibility to be employed for guided bone regeneration.